school and education






Dr Justen Manasa


Dr Justen Manasa


List of Publications

  1. Tzou PL, Rhee SY, Pond SLK, Manasa J, Shafer RW. Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy. Sci Data. 2018 Jul 24;5:180147. doi: 10.1038/sdata.2018.147. PubMed PMID: 30040081; PubMed Central PMCID: PMC6057438.
  2. Chimukangara B, Manasa J, Mitchell R, Nyabadza G, Katzenstein D, et al. Community Based 3Antiretroviral Treatment in Rural Zimbabwe. AIDS Res Hum Retroviruses. 2017 Sep 13;PubMed PMID: 28899102.
  3. Manasa J, Varghese V, Pond SLK, Rhee SY, Tzou PL, et al. Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors. Sci Rep. 2017 Sep 14;7(1):11559. PubMed PMID: 28912582.
  4. Ratmann O, Wymant C, Colijn C, Danaviah S, Essex M, et al. HIV-1 full-genome phylogenetics of generalized epidemics in sub-Saharan Africa: impact of missing nucleotide characters in next-generation sequences. AIDS Res Hum Retroviruses. 2017 May 25;PubMed PMID: 28540766; NIHMSID: EMS73006; PubMed Central PMCID: PMC5597042.
  5. Chimukangara B, Varyani B, Shamu T, Mutsvangwa J, Manasa J, et al. HIV drug resistance testing among patients failing second line antiretroviral therapy Comparison of in-house and commercial sequencing. J Virol Methods. 2017 May;243:151-157. PubMed PMID: 27894862; NIHMSID: NIHMS854678; PubMed Central PMCID: PMC5393912.
  6. Modukanele K, Sherwin J, White E, Manasa J, Zijenah LS, et al. Envelope Tropism and Diversity of Subtype C HIV among pregnant Women in Zimbabwe. Clinical Research in HIV/ AIDS. 2017 April 28; 4(2):1038.
  7. Rossouw TM, Nieuwoudt M, Manasa J, Malherbe G, Lessells RJ, et al. HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa. HIV Med. 2017 Feb;18(2):104-114. PubMed PMID: 27353262.
  8. Manasa J, Danaviah S, Lessells R, Elshareef M, Tanser F, et al. Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa. AIDS Res Hum Retroviruses. 2016 Aug;32(8):763-9. PubMed PMID: 27002368; PubMed Central PMCID: PMC4971422.
  9. Manasa J, Katzenstein D. Editorial Commentary: Scaling Up Antiretroviral Therapy in Africa: Are We There Yet?. Clin Infect Dis. 2016 Feb 15;62(4):519-20. PubMed PMID: 26561533.
  10. Manhanzva MT, Mutsvangwa J, Beck IA, Frenkel LM, Tshabalala M, et al. The Burden of HIV Associated Drug Resistance Mutations in an Early Infant Diagnosis Program: A Glance through the Paediatric Window of Zimbabwe. Infectious Diseases and Therapy . 2015; 3(1).
  11. Kiepiela P, Manasa J, Moosa M, Moodley P, Gordon M, et al. HIV Drug Resistance Patterns at the Epicentre of the HIV-1 Epidemic in KwaZulu-Natal, South Africa 2003-2013. Journal of AIDS & clinical research. 2014 April 25; 5(5).
  12. Manasa J, Danaviah S, Pillay S, Padayachee P, Mthiyane H, et al. An affordable HIV-1 drug resistance monitoring method for resource limited settings. J Vis Exp. 2014 Mar 30;(85)PubMed PMID: 24747156; NIHMSID: EMS58421; PubMed Central PMCID: PMC4024245.
  13. Lessells RJ, Stott KE, Manasa J, Naidu KK, Skingsley A, et al. Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges. BMC Health Serv Res. 2014 Mar 7;14:116. PubMed PMID: 24606875; PubMed Central PMCID: PMC3973961.
  14. Pillay S, Bland RM, Lessells RJ, Manasa J, de Oliveira T, et al. Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort. AIDS Res Ther. 2014 Jan 20;11(1):3. PubMed PMID: 24444369; PubMed Central PMCID: PMC3922737.
  15. Manasa J, Lessells R, Rossouw T, Naidu K, Van Vuuren C, et al. Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in southern Africa. Database (Oxford). 2014;2014:bat082. PubMed PMID: 24504151.
  16. Singh L, Parboosing R, Manasa J, Moodley P, de Oliveira T. High level of HIV-2 false positivity in KwaZulu-Natal province: a region of South Africa with a very high HIV-1 subtype C prevalence. J Med Virol. 2013 Dec;85(12):2065-71. PubMed PMID: 23959597.
  17. Manasa J, Lessells RJ, Skingsley A, Naidu KK, Newell ML, et al. High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa. PLoS One. 2013;8(8):e72152. PubMed PMID: 23991055; PubMed Central PMCID: PMC3749184.
  18. Manasa J, Katzenstein D, Cassol S, Newell ML, de Oliveira T. Primary drug resistance in South Africa: data from 10 years of surveys. AIDS Res Hum Retroviruses. 2012 Jun;28(6):558-65. PubMed PMID: 22251009; PubMed Central PMCID: PMC3358100.
  19. Tshabalala M, Manasa J, Zijenah LS, Rusakaniko S, Kadzirange G, et al. Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. PLoS One. 2011;6(6):e21241. PubMed PMID: 21698125; PubMed Central PMCID: PMC3116901.
  20. de Oliveira T, Shafer RW, Seebregts C. Public database for HIV drug resistance in southern Africa. Nature. 2010 Apr 1;464(7289):673. doi: 10.1038/464673c. PubMed PMID: 20360715; PubMed Central PMCID: PMC4767176.
  21. Dalai SC, de Oliveira T, Harkins GW, Kassaye SG, Lint J, et al. Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. AIDS. 2009 Nov 27;23(18):2523-32. PubMed PMID: 19770693; NIHMSID: NIHMS191722; PubMed Central PMCID: PMC2923658.
  22. Manasa J, Musabaike H, Masimirembwa C, Burke E, Luthy R, et al. Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clin Vaccine Immunol. 2007 Mar;14(3):293-8. PubMed PMID: 17267593; PubMed Central PMCID: PMC1828850.

Dr Pasipanodya Nziramasanga

Senior Lecturer

Dr Pasipanodya Nziramasanga

List of Published Articles

  1. P. Nziramasanga & David M. Lupan (1985) : Elastase activity of Coccidioides Immitis. Journal of Medical Microbiology Vol. 19 page 109-114.

  1. P Nziramasanga & D.M. Lupan (1985: Elastase activity of Fungi with Anamorphs similar to Coccidioidis immitis. Mycopathologia, Dec,92 (3) page 169-71.

  1. P Nziramasanga & P M Shah and W. Stille (1993): Control of intracellular growth of Mycobacterium fortuitum by human monocytes in vitro. Journal of Chemotherapy Vol. 5 (2) Page 103 – 106.

  1. P. Nziramasanga & D.M. Lupan (1986): Collagenolytic activity of Coccidiodes immitis.Infection and Immunity 52 (1) page 360 – 361

  1. P. Nziramasnga, P.M. Shah and W. Stille (1993): Resistance of Mycobacterium fortuitum to killing by Monocytes- Derived Macrophages. Rev. Espanol Quimioterapia Macrh Vol. 6 (1)

  1. D.T Mcleod, P. Neil, J.R. Robertson, A.S. Latif, J.C. Emmanuel, J.E. Els, L.K.Z. Gwanzura, F.E.J.Trijssenaar, P. Nziramasanga, G.R. Jongeling, D.A. Katzenstein, N. Nkanga and S.B. Lucas (1989): Pulmonary disease in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, pg 694-97

  1. Interviews E.W., Ch. A Thomas, P. Nziaramasanga, P. Kurz, J. Vlachoyannis and P.M. Shah (1990): Influence of Ciprofloxacin on the Phagocystosis of Staphylococci, E. coli and P. aeruginosa by Human Peritoneal Macrophages. Revista espanol de Quimioterapia 3 (3): pg 137 – 40

  1. P. Nziramasnga, P.M. Shah and W. Stille. (1995): Intercellular Antimycobacterial activity of ciprofloxacin and ofloxacin in Mycobacterium fortuitum infected human polymorphonuclear leukocytes. International Journal of Immunopathology and Pharmacology Vol. 8, no. 3: pg 209 – 215

  1. C.L. Obi, B. Makandiramba, V. Robertson, S.A Tswana, S.R. Moyo, P. Nziramasanga (1998): In viro activity of piperacillin and tazobactam combination against clinically significant bacteria.. East Africa Medical Journal, Vol 75, no 3: pg 161 – 164

  1. Obi C.L., Makandiramba B, Tswana S.A., Robertson V.J., Moyo S.R., Nziramasanga P (1999): In-vitro disk diffusion sensitivity of meropenem against bacterial pathogens in Harare. East Africa Medical Journal 76 365

  1. R.T. Mavenyengwa and P. Nziramasanga (2003): Use of culture methods for recovery of atypical mycobacteria from stools of AIDS patients. Central African Journal of Medicine Vol49 (3/4); pg 31-37, 2003

  1. R.T. Mavenyengwa, P. Masunga, E. Meque, T. Kudinha, S.R. Moyo, L. Bevanger, K. Bergh, P. Nziramasanga and T. Mapako (2006): Streprococcus agalactiae (Group B Streptococcus (GBS) colonization and persistence in pregnancy; a comparison of two diverse communities (rural and urban). Central Africa Journal of Medicine Vol52 (3/4); pg 8-13, 2006

  1. Mtapuri-Zinyowera S, Ruhanya V, Midzi N, Berejena C, Chin'ombe N, Nziramasanga P, Nyandoro G, Mduluza T. (2014): Human parasitic protozoa in drinking water sources in rural Zimbabwe and their link to HIV infection. Germs. Dec 1;4(4):86-91

  1. Mukaratirwa A, Berejena C, Nziramasanga P, Shonhai A, Mamvura TS, Chibukira P, Mucheuki I, Mangwanya D, Kamupota M, Manangazira P, Tapfumaneyi C, Gerede R, Munyoro M, Mwenda JM, Mphahlele JM, Seheri ML, Peenze I, Gonah AN, Maruta A, Tengende MB (2014): Epidemiologic and genotypic characteristics of rotavirus strains detected in children less than 5 years of age with gastroenteritis treated at 3 pediatric hospitals in Zimbabwe during 2008-2011. Pediatr Infect Dis J. Jan;33 Suppl 1:S45-8.

  1. Chimhuya S, Manangazira P, Mukaratirwa A, Nziramasanga P, Berejena C, Shonhai A, Kamupota M, Gerede R, Munyoro M, Mangwanya D, Tapfumaneyi C, Byabamazima C, Shibeshi EM, Nathoo KJ. (2015): Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe. BMC Public Health. Mar 27;15:2 94.

  1. Mamvura TS, Chin'ombe N, Ruhanya V, Nziramasanga P. (2015): Seroprevalence of rubella virus IgG in pregnant women in Harare, Zimbabwe. Germs.2 Jun 5(2):50-2

  1. L. Padya, N. Chin’ombe, M. Magwenzi, J. Mbanga, P. Nziramasanga (2015): Molecular Identification of Mycobacterium Species of Public Health Importance In Cattle In Zimbabwe by 16s RNA Gene Sequencing. The Open Microbiology Journal Vol 9, pg 1-12

  1. Chin’ombe N., E. Munemo, M. Magwenzi, B. Muzividzi and Nziramasanga P. (2015) First cases of Mycobacterium elephantis in Zimbabwe revealed by 16 S Ribosequencing Archives of Clinical Microbiology Vol 6 (4) : 10 1-3

  1. Chin’ombe N., B. Muzividzi, E. Munemo, Nziramasanga P. (2016) : Molecular identification of Nontuberculous Mycobacteria in humans in Zimbabwe using 16S Ribosequencing. The Open Microbiology Journal Vol 10 : 3-13

  2. Musona-Rukweza J., C. Haruzivishe, F. Muchabaiwa Gidiri, P.Nziramasanga and B. Stray-Pedersen (2017) Asymptomatic Bacteriuria in Pregnancy : A concept Analysis Journal of Microbiology Research and Reviews Vol 4 (1) : 1 – 5

21. Matare T., Nziramasanga P., Gwanzura L. and Robertson V. (2017) Experimental germ tube induction in Candida albicans : An evaluation of the effect of sodium bicarbonate on morphogenesis and comparison with pooled human serum. BioMedResearch International Volume 2017 (2017), Article ID 1976273: 1 –5 https/

  1. Musona-Rukweza J., Gidiri Muchabaiwa F., Nziramasanga P., Stray-Pedersen Babill and Haruzivishe C. O. (2017) Isolated Bacterial Uropathogens among Pregnant Women Diagnosed with Asymptomatic Bacteriuria in Harare, Zimbabwe Microbiology Research Journal International Vol 22 (3) : 1 – 7

  1. Musona –Rukweza J., Nziramasanga P., Gidiri Muchabaiwa F., Haruzivishe C. O. and Stray-Pedersen Babil (2017) Effectiveness of Griess Nitrite Test on Screening Asymptomatic Bacteriuria in Pregnancy : A Cross Sectional Study in Harare, Zimbabwe Journal of Advances in Microbiology Vol 5 (2) : 1 - 9

  1. Musona-Rukweza J., F. Gidiri Muchabaiwa, P. Nziramasanga, C. Haruzivishe and B. Stray-Pedersen (2017) Prevalence of asymptomatic bacteriuria among pregnant women: a cross-sectional study in Harare, Zimbabwe. Perinatal Journal Vol 25 (4) : 133 – 138

  2. Musona-Rukweza J., Nziramasanga P, Muchabaiwa Gidiri F., Haruzivishe C. O and Stray-Pedersen B. (2018) Antibiotic susceptibility of bacterial strains causing asymptomatic bacteriuria in pregnancy : A cross-sectional study in Harare, Zimbabwe MOJ Immunology 2018, Volume 6 (1) : 00184 : page 1 - 6.

Dr Rachael Mandishora


Dr Rachael Mandishora


  •  Attained Doctor of Philosophy Degree in Molecular Virology, 2018.
  •  Completed a UZ-PERFECT (Promoting Excellence in Research and Faculty Enhanced Career Training) fellowship 2016-2018.
  • Currently a Clayton-Dedonder Fellow.

List of publications:

  1. Racheal S. Dube Mandishora, Kristina S Gjøtterud, Sonja Lagström, Babill Stray-Pedersen, Nyasha Chin'ombe, Kerina Duri, Mari Nygård, ​Irene Kraus Christiansen, Ole Herman Ambur, Mike Z. Chirenje,​ Trine B Rounge. Intra-host sequence variability in human papillomavirus. Papillomavirus Research, 2018 April 30. 

  1. Racheal S. Dube Mandishora, Irene K. Christiansen, Nyasha Chin’ombe, Kerina Duri, Bernard Ngara, Trine B. Rounge, Roger Meisal, Ole Herman Ambur, Joel M. Palefsky, Babill Stray-Pedersen, Zvavahera M. Chirenje. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe (Journal of Medical Virology, 2017 Apr 8. doi: 10.1002/jmv.24825.

  1. Faustinos Tatenda Takawira, Racheal Shamiso Dube Mandishora, Zephaniah Dhlamini, Ellen Munemo, Babill Stray-Pedersen. Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods. The Pan African Medical Journal. 2017;27:145. doi:10.11604/pamj.2017.27.145.10883

  2.  Takudzwa Matuvhunye, Racheal S Dube-Mandishora, Nyasha, Chin’ombe, Graham Chakafana, Joshua Mbanga, Edward Zumbika, Babill Stray-Pedersen. Genotyping Human Papillomavirus in Women Attending Cervical Cancer Screening Clinic In Harare, Zimbabwe. British Microbiology Research Journal 16(6): 1-9, 2016, Article no.BMRJ.28481

  3. Dube-Mandishora Racheal S, Dhlamini Zephaniah, Mutetwa Reggie, Duri Kerina, Stray-Pedersen Babill, Mason Peter. Diagnosis of multi - drug resistant Tuberculosis mutations using Hain line probe assay and GeneXpert: a study done in Zimbabwe. British journal of medicine and medical research. 2014. 5(8): 1044-1052.

Dr Rooyen T. Mavenyengwa

Chairperson & Associate Professor

Dr Rooyen T. Mavenyengwa

DPhil. Molecular Microbiology (Norwegian Univ. of Scie & Tech, Trondheim, Norway); MSc Medical Microbiology, (UZ); (UZ); Grad CE (UZ); BSc (H) Biological Sciences

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.">

Professor Rooyen T Mavenyengwa joined the University of Zimbabwe, Department of Medical Microbiology in January 2002 as a Lecturer from The Biomedical Research and Training Institute (BRTI) where he had worked as a research assistant. He holds a BSc (Hons) in Biological Sciences, MSc in Medical Microbiology, both from the University of Zimbabwe in addition to a Post Graduate Certificate in Education from the same institution. He graduated with a DPhil from the Norwegian University of Science and Technology in Trondheim, Norway in 2012. Professor Mavenyengwa was promoted to Senior Lecturer Grade on 1 January 2013. He is the first African scholar to use molecular techniques to characterize Group B streptococcus (GBS) which causes infections mainly in pregnant mothers and children with a view to identifying suitable and potential vaccine candidates relevant for the local population. His pioneering work on GBS was done in collaboration with international partners from Norway, South Africa and Namibia. He has published numerous research articles in peer-reviewed high impact journals and has presented his scientific research work at local, regional and international conferences and symposia across the globe. His main research highlight is the discovery of the new surface-anchored protein in GBS called the “Z” protein. He has since published a book on molecular characterization of Group B Streptococcus. His other research interests include antibiotic resistance testing, HIV and AIDS, and other viruses of public health importance, Transfusion Transmissible infections (TTIs), Cryptococccus and Tuberculosis. Professor Mavenyengwa has received other numerous academic, research and travel awards in recognition of his outstanding contribution to Medical Microbiology scientific research. His main area of specialization is Medical Bacteriology focusing on Streptococcology and Molecular Biology which he passionately teaches to both undergraduate and postgraduate medical students. He coordinates and facilitates the training of the HIV Rapid testing course in partnership with the Medical Laboratory and Clinical Scientists Council (MLCSC). He also leads a vibrant team at the WHO-funded Zimbabwe National Virology Laboratory which is mandated by the Ministry of Health and Child Care to carry out routine diagnostic and surveillance on Polio, Rubella, Measles and Rota viruses for Zimbabwe and Malawi. He was appointed Chairman of the Department of Medical Microbiology on 1 October 2016, the appointment which he holds to date.

List of Publications

  1. Gudza-Mugabe M Mavenyengwa RT, Mapingure MP, Mtapuri-Zinyowera S, Tarupiwa A, Robertson VJ. 2017. Antibiotic resistance in bacterial pathogens causing meningitis in children at Harare Central Hospital, Zimbabwe. Central African Journal of Medicine. 63(4/6):36-41

  2. Samakande D, Mandisodza A, Chikwasha V, Mavenyengwa RT, Mavunganidze G, Parirewa J. 2017. Detection of malaria parasites in donated blood in Zimbabwe using the rapid SD Bioline test kit. IJRDO-Journal of Health Sciences and Nursing. 2(5):70-76

  3. Mavenyengwa RT, Shaduka E, Maposa I. 2017. Epidemiology of Mycobacterium tuberculosis detected using the Xpert MTB/RIF assay and microscopy in Namibia. Infectious Diseases of Poverty. 6:3

  4. Mavenyengwa RT and Nyamayaro T. 2016. Developing a curriculum for health professional students on point of care tests for medical diagnosis. International Journal of Medical Education. 7:244-245.

  5. Monyama MC, Bolukaoto JY, Chukwu MO, Maloba MRB, Moyo SR, Mavenyengwa RT*, Nchabeleng M, Lebelo SL. 2016. Group B streptococcus colonization in pregnant women at Dr. George Mukhari Hospital, South Africa. South African Journal of Infectious Diseases. 1(1): 1-5

  6. Lekala SM, Mavenyengwa RT*, Bolukaoto JY, Monyama CM, Chukwu MO, Nchabeleng M, Lebelo SL, Monokoane ST, Moyo SR and Tshepuwane C. 2015. Risk factors associated with group B streptococcus colonization and effect on pregnancy outcome. Journal of Gynecology and Obstetrics. 3(6):121-128.

  7. Chukwu MO, Mavenyengwa RT*, Monyama CM, Bolukaoto JY, Lebelo SL, Maloba MRB, Nchabeleng M, Moyo SR. 2015. Antigenic distribution of Streptococcus agalactiae isolates from pregnant women at Garankuwa hospital – South Africa. GERMS. 5(4):125-133.

  8. Niitembu JJV, Maposa I, Mavenyengwa RT*. 2015. A retrospective study of the variability in etiological agents of urinary tract infections among patients in Windhoek- Namibia. Open Journal of Microbiology. 5(4):184-192.

  9. Bolukaoto JY, Monyama CM, Chukwu MO, Lekala SM, Nchabeleng M, Maloba MRB, Mavenyengwa RT*, Lebelo SL, Monokoane ST, Tshepuwane C, and Moyo SR. 2015. Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa. BMC Research Notes. 8:364-70.

  10. Gudza-Mugabe M, Robertson V, Mapingure MP, Mtapuri-Zinyowera S, Mavenyengwa RT. 2015. Bacterial paediatric meningitis laboratory diagnosis. Journal of Cell Science and Therapy. 6:204-9.

  11. Makuni N, Simango C, Mavenyengwa RT*. 2015. Prevalence of bacterial contamination in blood and blood products at the National Blood Service Zimbabwe. J Infect Dev Ctries. 9(4):421-4.

  12. Fillemon Haimbodi, Rooyen Mavenyengwa, Bruce H Noden. 2014. Knowledge and practices of residents in north Namibian towns with regard to rabies and pet care. South Afr J Infect. 29(4):141-146.

  13. Mavenyengwa RT, Mukesi M, Chipare and Shoombe E. 2014. Prevalence of Human Immunodeficiency Virus, syphilis, hepatitis B and C in blood donations in Namibia. BMC Public Health. 14:424-430.

  14. Johan Maeland, Andreas Radtke, Randi Lyng, and Rooyen T Mavenyengwa. 2013. Novel aspects of the Z and R3 antigens of Streptococcus agalactiae revealed by immunological testing. Clin. Vaccine Immunol. 20(4): 607-612.

  15. Augusta I. Kvam, Rooyen T. Mavenyengwa, Andreas Radtke, Johan A. Maeland. 2011. Streptococcus agalactiae alpha-like protein 1(Alp1) possesses both cross-reacting and Alp1-specific epitopes. Clin. Vaccine Immunol. 18(8):1365-70.

  16. Rooyen T. Mavenyengwa, Johan A. Maeland, Sylvester R. Moyo. 2010. Serotype markers in a Streptococcus agalactiae strain collection from Zimbabwe. Indian J. Med. Microbiol. 28(4):313-319.

  17. Rooyen T. Mavenyengwa, Sylvester Rogers Moyo, Svein Arne Nordbø. 2010. Streptococcus agalactiae colonization and correlation with HIV-1 and Hepatitis B seroprevalence in pregnant women in Zimbabwe. Eur. J. Obst. Gyn. Reprod. Biol.150(1):34-8.

  18. Rooyen T. Mavenyengwa, Jan Egil Afset, Berit Schei , Synnøve Berg, Tone Caspersen, Håkon Bergseng, Sylvester R. Moyo. 2010. Group B Streptococcus (GBS) colonization during pregnancy and maternal-fetal transmission in Zimbabwe. Acta Obstet. Gynecol. Scand. 89(2):250-5.

  19. Rooyen T. Mavenyengwa, Johan A. Maeland, Sylvester R. Moyo. 2009. Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B Streptococcus from Zimbabwe. Clin. Vaccine Immunol. 16(9):1302-1308

  20. Rooyen T. Mavenyengwa, Johan A. Maeland, Sylvester R. Moyo. 2008. Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting. Clin. Vaccine Immunol. 15(9):1420-1424.

  21. Rooyen T. Mavenyengwa, P Masunga, E Meque, T Kudinha, SR Moyo, L Bevanger, K Bergh, P Nziramasanga and T Mapako. 2006. Streptococcus agalactiae (Group B streptococcus) colonization and persistence, in pregnancy; a comparison of two diverse communities (rural and urban). Cent. Afr. J. Med. 52(3/4):38-43.

  22. Rooyen T. Mavenyengwa and P Nziramasanga. 2003. Use of culture methods for recovery of atypical mycobacteria from stools of AIDS patients. Cent. Afr. J. Med. 49(3/4):31-7.



Rooyen T. Mavenyengwa. Molecular, Clinical Microbiology and Diagnosis of Group B streptococcus. Lambert Academic Publishing. Saarbrücken, Germany. ISBN 978-3-659-81156-2. 88 pages. 01. 12. 2015.

Professor Nyasha Chin’ombe

Senior Lecturer

Professor Nyasha Chin’ombe

PhD in Medical Microbiology (UCT), MSc in Biotechnology (UZ), BSc in Biological Sciences (UZ)


Outstanding Achievements

  1. University of Zimbabwe Research Board funding: Mycobacteria Research project: 2015-2018.

  2. Claude Leon Foundation Postdoctoral Fellowship, 2011-2012: University of Cape, Cape Town, Division of Human Genetics. RSA.

  3. Emory-South Africa NRF Drug Discovery Post-doctoral Fellowship, 2010-11: Emory Vaccine Center, Emory University, Atlanta, USA.

  4. Global HIV Vaccine Enterprise scholarship to attend 5th African AIDS Vaccine Programme (AAVP) Forum, 13-15 December, 2009, Kampala, Uganda.

  5. Bill & Melinda Gates Foundation Award for registration subsidy of the Keystone Conference on Overcoming the Crisis of TB and AIDS. Arusha, Tanzania, October, 2009.

  6. International Society for Infectious Diseases scholarship for registration for the 13th International Conference on Infectious Diseases Conference, Kuala Lumpur, June 2008.

  7. National Research Foundation/University of Cape Town Travel fellowship to attend the 13th International Conference on Infectious Diseases Conference, Kuala Lumpur, June 2008.

  8. International 2008 AIDS Vaccine Complementary Registration Scholarship to attend 2008 International AIDS Vaccine Conference in Cape Town, South Africa, October, 2008.

  9. Global Health Travel Award to attend Keystone Symposia on Challenges of Global Vaccine Development, Cape Town, South Africa, October 2007.

  10. NRF SARChI Chair postdoctoral fellowship, 2007-2009,UCT.

  11. World Health Organization scholarship to attend 7th Global Vaccine Research Forum in Bangkok, Thailand, Dec. 2006.

  12. International 2005 AIDS Vaccine Scholarship to attend 2005 AIDS Vaccine Conference in Montreal, Canada, September 2005.

  13. Africa Genome Institute 2005 Fellowship to attend the Africa Genome Conference in Nairobi, March 2005.

  14. International 2004 AIDS Vaccine Scholarship to attend AIDS Vaccine Conference in Lausanne, Switzerland, September 2004.

  15. South African AIDS Vaccine Initiative (SAAVI) Scholarship to study PhD in Medical Microbiology (Virology) at University of Cape Town, 2001-2006..

  16. International Livestock Research Institute Graduate Fellowship to do MSc (Biotechnology) research project at the Institute, 1996.

  17. Hiram Wild Memorium Prize and University Book Prizes for being best student in Coursework and Examination for the BSc Honours degree in Biological Sciences, 1993.


Lis of Publications

  1. Dube Mandishora RS, Gjøtterud KS, Lagström S, Stray-Pedersen B, Duri K, Chin'ombe N, Nygård M, Christiansen IK, Ambur OH, Chirenje MZ, Rounge TB. Intra-host sequence variability in human papillomavirus. Papillomavirus Res. 2018. 5:180-191.

  2. Manjeese W, Muzividzi B, Mbanga J, Mufandaedza J, Chin’ombe N. RpoB Gene-Based Characterization of Non-Tuberculous Mycobacteria in Zimbabwe. Journal of Advances in Microbiology. 2017: 6(1): 2456-7116.

  3. Dube-Mandishora RS, Christiansen IK, Chin'ombe N, Duri K, Ngara B, Rounge TB, Meisal R, Ambur OH, Palefsky JM, Stray-Pedersen B, Chirenje ZM. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe. J Med Virol. 2017;89:1671–1677.

  4. Mbiri W, Chin’ombe N. Molecular Identification of Plasmodium Species in Malaria in Zimbabwe by Mitochondrial DNA Sequencing. International Journal of TROPICAL DISEASE & Health. 2017. 21(2): 1-8.

  5. Sebata NL, Chin’ombe N. Molecular Detection and Typing of Genital Human Papillomavirus among Female Medical and Nursing Students in Harare, Zimbabwe. International STD Research & Reviews. 2017. 5(1): 1-8.

  6. Baudi I, Iijima S, Chin’ombe N, Mtapuri-Zinyowera S, Murakami S, Isogawa M, Hachiya A, Iwatani Y, Tanaka Y. Molecular epidemiology of co-Infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe. Journal of Medical Virology. 2017. 89: 257-266.

  7. Mandishora RSD, Christiansen IK, Chin'ombe N, Duri K, Rounge TB, Meisal R, Ambur OH, Stray-Pedersen B, Chirenje ZM. Do HIV-infected and Uninfected Women Have Different Human Papilloma Virus Genotypes Distribution: A Cross Sectional Study Carried out in Zimbabwe. AIDS Research & Human Restroviruses, 2016, 32 (Supplement 1): 280.

  8. Nyazika TK, Hagen F, Machiridza T, Kutepa M, Masanganise F, Hendrick M, Boekhout T, Magombei T, Siziba T, Chin’ombe N, Mateveke K, Meis JF, Robertson VJ. Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in sub-Sahara Africa. Journal of Medical Microbiology. 2016. 65:1281-1288.

  9. Chin’ombe N, Muzividzi B, Munemo E, Nziramasanga P. Molecular identification of nontuberculous mycobacteria in humans in Zimbabwe. 2016. International Journal of Infectious Diseases. 45 (Supplement 1): 169-170.

  10. Matuvhunye T, Dube-Mandishora RS, Chin’ombe N, Chakafana G, Mbanga R, Zumbika, Stray-Pedersen B. Genotyping human papillomavirus in women attending cervical cancer screening clinic in Harare, Zimbabwe. 2016. British Microbiology Research Journal. 2016. 16(6): 1-9.

  11. Chin’ombe N, Manjeese W, Munemo E. Molecular Detection of Mycobacterium tuberculosis Rifampicin Drug Resistance Using rpoB Gene Sequencing in Zimbabwe. British Microbiology Research Journal. 2016. 16(5): 1-6.

  12. Chin’ombe N, Muzividzi B, Munemo M, Nziramasanga P. Molecular Identification of Nontuberculous Mycobacteria in Humans in Zimbabwe Using 16S Ribosequencing. The Open Microbiology Journal. 2016; 10, 3-13.

  13. Matambo R, Nyandoro G, Mungofa S, Mutseyekwa FM, Ruhanya V, Mugomeri E, Chin’ombe N. Identifying factors associated with contracting typhoid during an outbreak in Harare, Zimbabwe. Journal of Contemporary Clinical Practice. 2016; 2: 9-17.

  14. Kouamou V, Chin’ombe N, Matimba A, Kadzatsa W, Nyandoro G, Musarurwa C. P53 Codon 72 Polymorphism and the Risk of Cervical Cancer in Zimbabwean Women. International Journal of Tropical Disease and Health. 2016, 15(3): 1-6.

  15. Matambo R, Duri C, Ruhanya V, Mungofa S, Chadambuka E, Nyandoro G, Mugomeri E, Chin’ombe N. Evaluation of a Tuberculosis Surveillance System in the Harare City Health Department in Zimbabwe. International Journal of Tropical Disease and Health. 2016, 14(4): 1-10.

  16. Matambo R, Bare H, Mungofa S, Miti G, Ruhanya V, Nyandoro G, Chin’ombe N. Evaluation of the Antiretroviral Therapy Program at Wilkins Hospital in Zimbabwe. British Journal of Medicine & Medical Research. 2016; 11(4): 1-9.

  17. Padya L, Chin’ombe N, Magwenzi M, Mbanga M, Nziramasanga P. Molecular identification of Mycobacterium species of public health importance in cattle in Zimbabwe by 16S rRNA gene sequencing. The Open Microbiology Journal. 2015; 9, 38-42.

  18. Chin'ombe N, Munemo E, Magwenzi M, Muzividzi B, Nziramasanga N. First Cases of Mycobacterium elephantis in Zimbabwe Revealed by 16S Ribosequencing. Archives of Clinical Microbiology. 2015; 6:10.

  19. Chin’ombe N, Ruhanya V. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies. The Pan African Medical Journal. 2015;20:386.

  20. Mugomeri E, Senauoane MB, Ruhanya V, Chin’ombe N, Nyandoro G, Occurrence of HBV/HIV coinfection by laboratory values in Roma, Lesotho. GERMS. 2015;5:8-11.

  21. Tarupiwa A, Tapera S, Mtapuri-Zinyowera S, Gumbo P, Ruhanya V, Gudza-Mugabe M, Majuru NX, Chin’ombe N. Evaluation of TUBEX-TF and OnSite Typhoid IgG/IgM Combo Rapid Tests to Detect Salmonella enterica serovar Typhi During a Typhoid Outbreak in, Harare Zimbabwe. BMC Research Notes. 2015:8:50.

  22. Mamvura TS, Chin’ombe N, Ruhanya V, Nziramasanga P. Seroprevalence of rubella virus IgG in pregnant women in Harare, Zimbabwe. GERMS. 2015;5(2):50-52.

  23. Mugomeri E, Chatanga P, Lefunyane M, Ruhanya V, Nyandoro G, Chin’ombe N. Adherence to tuberculosis infection control guidelines by nurses in Lesotho. American Journal of Infection Control. 2015, 43(7):735-738.

  24. Midzi N, Mtapuri –Zinyowera S, Mutsaka MJ, Ruhanya V, Magwenzi M, Chin’ombe N, Nyandoro G, Marume A, Kumar N and Mduluza T. Impact of School Based Health Education on Knowledge, Attitude and Practice of Grade Three Primary School Children in Zimbabwe. J Community Med Health Educ. 2014, 4: 295.

  25. Chin’ombe N, Sebata NL, Ruhanya V, Matarira HT. Human Papillomavirus Genotypes in Cervical Cancer and Vaccination Challenges in Zimbabwe. Infectious Agents and Cancer. Infectious Agents and Cancer. 2014, 9:16.

  26. Chapman R, Bourn WR, Shephard E, Stutz H, Douglass N, Mgwebi T, Meyers A, Chin'ombe N, Williamson AL. The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen. PLoS One. 2014, 9(7):e103314.

  27. Mhandire K, Duri K, Kandawasvika G, Chandiwana P, Chin’ombe N, Kanyera RB, Stray-Pedersen B, Dandara C. CCR2, CX3CR1, RANTES and SDF1 genetic polymorphisms influence HIV infection in a Zimbabwean pediatric population. J Infect Dev Ctries 2014; 8(10):1313-1321.

  28. Mtapuri-Zinyowera S, Ruhanya V, Midzi N, Berejena C, Chin’ombe N, Nziramasanga P, Nyandoro G, Mduluza T. Human parasitic protozoa in drinking water sources in rural Zimbabwe and their link to HIV infection. GERMS. 2014;4:86-91.

  29. Chin'ombe N. Recombinant Salmonella enterica Serovar Typhimurium as a Vaccine Vector for HIV-1 Gag. Viruses. 2013, 5, 2062-2078.

  30. Chin’ombe N, Lebeko M, Kgatle M. Overexpression of recombinant HIV-1 Subtype C Tat and Nef in a Salmonella vaccine vector. Pan African Medical Journal. 2013, 16:19.

  31. Chin’ombe N, Ruhanya V. Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines. The Open Virology Journal. 2013, 7:121-126.

  32. Chin’ombe N, Msengezi O, Matarira HT. Microalbuminuria in patients with chronic kidney disease at Parirenyatwa Hospital in Zimbabwe. Pan African Medical Journal. 2013, 14,39

  33. Swart M, Skelton M, Wonkam A, Kannemeyer L, Chin’ombe N, Dandara D. CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics. Current Pharmacogenomics and Personalised Medicine 2012 10, 43-53.

  34. Chin’ombe N, Chavhunduka E, Matarira HT. Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe. Infectious Agents and Cancer 2009 4:15

  35. Chin'ombe N, Bourn WR, Williamson AL, Shephard EG. Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice. Virology Journal 2009 6:87.

  36. Chin'ombe N, Bourn WR, Williamson AL, Shephard EG. An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice. Gut Pathogens 2009 1:9.

  37. Chin’ombe N, Lebeko M and Williamson A-L. Prokaryotic expression and purification of HIV-1 Subtype C Gag for use in ELISAs. International Journal of Infectious Diseases 12 (Supplement 1), 2008.

  38. Kgatle M, Williamson A-L and Chin’ombe N, Expression of HIV-1 Subtype C Tat and Nef in Salmonella vaccine vector. AIDS Research and Human Retroviruses 24 (Supplement 1), 2008, 88.

  39. Lebeko M, Williamson A-L and Chin’ombe N, Purification of recombinant HIV-1 Subtype C Tat and Nef expressed from Escherichia coli. AIDS Research and Human Retroviruses 24 (Supplement 1), 2008, 96.

  40. Chin’ombe N, Shephard EG, Williamson A-L and Rybicki EP, Immunogenicity of HIV-1 Subtype C Gag plasmo-VLP vaccine. AIDS Research and Human Retroviruses 24 (Supplement 1), 2008, 139.

  41. Matarira HT, Mujaji WB, Chin’ombe N, Mlambo T, Nyamayaro T. The contribution of ZEQAS in the practice of laboratory medicine: 1989-1999. Journal of the Association for Laboratory Automation, 4(4) 1999, 75-77.

  42. Matarira H T, Chin’ombe N. Equipping a laboratory for cancer research in a developing country. Central African Journal of Medicine 44: 1998, 138-139.

  43. Chin’ombe N, Matarira, H. T. Genetic engineering: The biotechnology of miracles, hopes and fears. Central African Journal of Medicine 44, 1998, 188-189.

More Articles ...

Talk to us